Nuveen Asset Management, LLC Axcella Health Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.08 - $5.13 $199,426 - $332,162	-64,749 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.55 - $6.72 $34,024 - $50,252	-7,478 Reduced 10.35%	64,749 $308,000
Q4 2020 Feb 16, 2021	BUY	$4.24 - $5.97 $1,386 - $1,952	327 Added 0.45%	72,227 $375,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $5.91 $90,561 - $129,907	21,981 Added 44.03%	71,900 $333,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $109,091 - $285,716	37,106 Added 289.6%	49,919 $276,000
Q4 2019 Feb 14, 2020	BUY	$3.08 - $5.9 $39,464 - $75,596	12,813 New	12,813 $51,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.